Pasar al contenido principal

BIOLOGIA SINTETICA DE ELEMENTOS REGULADORES DE GENES MEDIANTE GENOMICA DE CELULAS INDIVIDUALES

PID2019-108082GA-I00

•
Nombre agencia financiadora Agencia Estatal de Investigación
Acrónimo agencia financiadora AEI
Programa Programa Estatal de I+D+i Orientado a los Retos de la Sociedad
Convocatoria Proyectos de I+D+i (Generación de Conocimiento y Retos Investigación)
Año convocatoria 2019
Plan Estatal 2017-2020 Plan Estatal de Investigación Científica y Técnica y de Innovación
Centro beneficiario FUNDACIO CENTRE DE REGULACIO GENOMICA

Resultados relacionados

Resultados totales (Incluyendo duplicados): 6
Encontrada(s) 1 página(s)

Repositorio Digital de la UPF
Publicación Artículo científico (JournalArticle)

Design principles of cell-state-specific enhancers in hematopoiesis

  • Frömel, Robert
  • Rühle, Julia
  • Bernal, Aina
  • Szu-Tu, Chelsea
  • Pacheco Pastor, Felix
  • Martínez Corral, Rosa, 1991-
  • Velten, Lars
During cellular differentiation, enhancers transform overlapping gradients of transcription factors (TFs) to highly specific gene expression patterns. However, the vast complexity of regulatory DNA impedes the identification of the underlying cis-regulatory rules. Here, we characterized 64,400 fully synthetic DNA sequences to bottom-up dissect design principles of cell-state-specific enhancers in the context of the differentiation of blood stem cells to seven myeloid lineages. Focusing on binding sites for 38 TFs and their pairwise interactions, we found that identical sites displayed both repressive and activating function as a consequence of cell state, site combinatorics, or simply predicted occupancy of a TF on an enhancer. Surprisingly, combinations of activating sites frequently neutralized one another or gained repressive function. These negative synergies convert quantitative imbalances in TF expression into binary activity patterns. We exploit this principle to automatically create enhancers with specificity to user-defined combinations of hematopoietic progenitor cell states from scratch., This study was financed by grants from the Spanish Ministry of Science, Innovation and Universities MCIU/AEI/10.13039/501100011033 (grant PID2019-108082GA-I00 to L.V.; and grant RYC2021-033860-I cofounded by European Union NextGenerationEU/PRTR to R.M.-C.), the Ministry of Science and Innovation (PID2022-142210NA-I00 funded by MCIN/AEI/10.13039/501100011033 / FEDER, UE to R.M.-C.; and pre-doctoral fellowship PRE2021-097675 funded by MCIN/AEI/10.13039/501100011033 and FSE+ to J.R.). This project has received funding from the European Union's Horizon Europe under the grant agreement no. 101041399 (ERC-StG AI4SYN to L.V.). F.P.P. was supported by the predoctoral program AGAUR-FI grants (2023 FI_I 00776), Joan Oró of the Secretariat of Universities and Research of the Department of Research and Universities of the Generalitat de Catalunya, and the European Social Fund Plus. The authors acknowledge support by the Spanish Ministry of Science and Innovation through the Centro de Excelencia Severo Ochoa (CEX2020-001049-S and MCIN/AEI /10.13039/501100011033) and the Generalitat de Catalunya through the CERCA programme and to the EMBL partnership. We are grateful to the CRG Core Technologies Programme for their support and assistance in this work. Research for this publication has been partially carried out in the Barcelona Collaboratorium for Modelling and Predictive Biology.
Repositorio Digital de la UPF
Publicación Artículo científico (JournalArticle)

Clonally resolved single-cell multi-omics identifies routes of cellular differentiation in acute myeloid leukemia

  • Beneyto Calabuig, Sergi
  • Szu-Tu, Chelsea
  • Velten, Lars
Inter-patient variability and the similarity of healthy and leukemic stem cells (LSCs) have impeded the characterization of LSCs in acute myeloid leukemia (AML) and their differentiation landscape. Here, we introduce CloneTracer, a novel method that adds clonal resolution to single-cell RNA-seq datasets. Applied to samples from 19 AML patients, CloneTracer revealed routes of leukemic differentiation. Although residual healthy and preleukemic cells dominated the dormant stem cell compartment, active LSCs resembled their healthy counterpart and retained erythroid capacity. By contrast, downstream myeloid progenitors constituted a highly aberrant, disease-defining compartment: their gene expression and differentiation state affected both the chemotherapy response and leukemia's ability to differentiate into transcriptomically normal monocytes. Finally, we demonstrated the potential of CloneTracer to identify surface markers misregulated specifically in leukemic cells. Taken together, CloneTracer reveals a differentiation landscape that mimics its healthy counterpart and may determine biology and therapy response in AML., This work was financially supported by the German Bundesministerium für Bildung und Forschung (BMBF) through the Juniorverbund in der Systemmedizin “LeukoSyStem” (FKZ 01ZX1911D to L.V. and S.R.) as well as the Verbundprojekt SMART-CARE (031L0212A to C.M.-T.), the Emerson foundation grant 643577 (to L.V.), grant PID2019-108082GA-I00 and PRE2020-093229 by the Spanish Ministry of Science, Innovation and Universities (MCIU/AEI/FEDER, UE), the German Research Foundation (DFG; projects MU1328/18-1 and MU1328/21-1 and MU1328/23-1 to C.M.-T.), and the German Cancer Aid (DKH; project 70113908 to C.M.-T.). L.V. acknowledges support of the Spanish Ministry of Science and Innovation to the EMBL partnership, the Centro de Excelencia Severo Ochoa and the CERCA Programme/Generalitat de Catalunya. C.M.-T., A.K.M., and J.-A.K. gratefully acknowledge the data storage service SDS@hd supported by the Ministry of Science, Research and the Arts Baden-Württemberg (MWK) and the German Research Foundation (DFG) through grant INST 35/1314-1 FUGG and INST 35/1503-1 FUGG. J.-A.K. acknowledges support of the Deutsche Gesellschaft für Hämatologie und Medizinische Onkologie e.V. (DGHO) and Deutsche José Carreras Leukämie-Stiftung e.V. through the José Carreras-DGHO-Promotionsstipendium.
Repositorio Digital de la UPF
Publicación Artículo científico (JournalArticle)

Emergence of activation or repression in transcriptional control under a fixed molecular context

  • Martínez Corral, Rosa, 1991-
  • Friedrich, Dhana
  • Frömel, Robert
  • Velten, Lars
  • Gunawardena, Jeremy
  • DePace, Angela H.
Transcription factors (TFs) can be both activators and repressors of gene transcription. This can manifest as "duality," where the transcriptional response increases (activation) with TF concentration in one context but decreases (repression) in another context, or as "nonmonotonicity," where, in the same context, the response increases in part of the concentration range and decreases outside that range. Here we use biophysical models of gene regulation to investigate how duality and nonmonotonicity relate to the interactions between a TF, Polymerase and the regulatory DNA. We distinguish two modes of TF action on Polymerase: "coherent," with interactions either positive or negative, and "incoherent," where interactions are a mix of both. For TFs that act incoherently from a single TF-DNA binding site, nonmonotonicity can arise, but only under nonequilibrium models. For single-site models, we show that nonmonotonicity can never happen under the common thermodynamic models of gene regulation, which consider equilibrium conditions and ignore the dissipative nature of the transcription process. Moreover, we show that merely changing the TF-DNA binding affinity, while keeping other features fixed, can tune the response between activation and repression, with responses either evaluated as a function of TF concentration or site number. Using the mammalian Sp1 as a case study and synthetically designed target sequences, we find experimental evidence for nonmonotonicity, and activation or repression tuned by affinity, which we interpret as evidence of incoherent action. Our work highlights the importance of moving from a TF-centric view to a systems view when reasoning about transcriptional control., This work was supported by the Howard Hughes Medical Institute (A.H.D.), NSF grant MCB-1715184 (D.F. and A.H.D.), NIH grant R01GM122928 (J.G. and A.H.D.), NSF CAREER IOS-1452557 (A.H.D.), the Lynch Foundation (D.F.), European Molecular Biology Organisation (EMBO) Fellowship ALTF683-2019 (R.M.-C.), RYC2021-033860-I funded by MCIN/AEI/10.13039/501100011033 and by European Union NextGenerationEU/PRTR (R.M.-C.), PID2022-142210NA-I00 (R.M.-C.), and PID2019-108082GA-I00 (L.V.) by the Spanish Ministry of Science, Innovation and Universities (MCIU/AEI/FEDER, UE). L.V. also acknowledges support of the Spanish Ministry of Science and Innovation to the European Molecular Biology Laboratory (EMBL) partnership. R.M.-C., L.V., and R.F. acknowledge support of the Spanish Ministry of Science and Innovation through the Centro de Excelencia Severo Ochoa (CEX2020-001049-S, MCIN/AEI/10.13039/501100011033) and the Generalitat de Catalunya through the Centres de Recerca de Catalunya (CERCA) programme and are grateful to the Center for Genomic Regulation Core Technologies Programme for their support and assistance in this work. Research for this publication has been partially carried out in the Barcelona Collaboratorium. A.H.D. is a Senior Director - Scientific Program Officer of the HHMI.
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

Emergence of activation or repression in transcriptional control under a fixed molecular context

  • Martínez Corral, Rosa, 1991-
  • Friedrich, Dhana
  • Frömel, Robert
  • Velten, Lars
  • Gunawardena, Jeremy
  • DePace, Angela H.
Transcription factors (TFs) can be both activators and repressors of gene transcription. This can manifest as "duality," where the transcriptional response increases (activation) with TF concentration in one context but decreases (repression) in another context, or as "nonmonotonicity," where, in the same context, the response increases in part of the concentration range and decreases outside that range. Here we use biophysical models of gene regulation to investigate how duality and nonmonotonicity relate to the interactions between a TF, Polymerase and the regulatory DNA. We distinguish two modes of TF action on Polymerase: "coherent," with interactions either positive or negative, and "incoherent," where interactions are a mix of both. For TFs that act incoherently from a single TF-DNA binding site, nonmonotonicity can arise, but only under nonequilibrium models. For single-site models, we show that nonmonotonicity can never happen under the common thermodynamic models of gene regulation, which consider equilibrium conditions and ignore the dissipative nature of the transcription process. Moreover, we show that merely changing the TF-DNA binding affinity, while keeping other features fixed, can tune the response between activation and repression, with responses either evaluated as a function of TF concentration or site number. Using the mammalian Sp1 as a case study and synthetically designed target sequences, we find experimental evidence for nonmonotonicity, and activation or repression tuned by affinity, which we interpret as evidence of incoherent action. Our work highlights the importance of moving from a TF-centric view to a systems view when reasoning about transcriptional control., This work was supported by the Howard Hughes Medical Institute (A.H.D.), NSF grant MCB-1715184 (D.F. and A.H.D.), NIH grant R01GM122928 (J.G. and A.H.D.), NSF CAREER IOS-1452557 (A.H.D.), the Lynch Foundation (D.F.), European Molecular Biology Organisation (EMBO) Fellowship ALTF683-2019 (R.M.-C.), RYC2021-033860-I funded by MCIN/AEI/10.13039/501100011033 and by European Union NextGenerationEU/PRTR (R.M.-C.), PID2022-142210NA-I00 (R.M.-C.), and PID2019-108082GA-I00 (L.V.) by the Spanish Ministry of Science, Innovation and Universities (MCIU/AEI/FEDER, UE). L.V. also acknowledges support of the Spanish Ministry of Science and Innovation to the European Molecular Biology Laboratory (EMBL) partnership. R.M.-C., L.V., and R.F. acknowledge support of the Spanish Ministry of Science and Innovation through the Centro de Excelencia Severo Ochoa (CEX2020-001049-S, MCIN/AEI/10.13039/501100011033) and the Generalitat de Catalunya through the Centres de Recerca de Catalunya (CERCA) programme and are grateful to the Center for Genomic Regulation Core Technologies Programme for their support and assistance in this work. Research for this publication has been partially carried out in the Barcelona Collaboratorium. A.H.D. is a Senior Director - Scientific Program Officer of the HHMI.
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

Clonally resolved single-cell multi-omics identifies routes of cellular differentiation in acute myeloid leukemia

  • Beneyto Calabuig, Sergi
  • Szu-Tu, Chelsea
  • Velten, Lars
Inter-patient variability and the similarity of healthy and leukemic stem cells (LSCs) have impeded the characterization of LSCs in acute myeloid leukemia (AML) and their differentiation landscape. Here, we introduce CloneTracer, a novel method that adds clonal resolution to single-cell RNA-seq datasets. Applied to samples from 19 AML patients, CloneTracer revealed routes of leukemic differentiation. Although residual healthy and preleukemic cells dominated the dormant stem cell compartment, active LSCs resembled their healthy counterpart and retained erythroid capacity. By contrast, downstream myeloid progenitors constituted a highly aberrant, disease-defining compartment: their gene expression and differentiation state affected both the chemotherapy response and leukemia's ability to differentiate into transcriptomically normal monocytes. Finally, we demonstrated the potential of CloneTracer to identify surface markers misregulated specifically in leukemic cells. Taken together, CloneTracer reveals a differentiation landscape that mimics its healthy counterpart and may determine biology and therapy response in AML., This work was financially supported by the German Bundesministerium für Bildung und Forschung (BMBF) through the Juniorverbund in der Systemmedizin “LeukoSyStem” (FKZ 01ZX1911D to L.V. and S.R.) as well as the Verbundprojekt SMART-CARE (031L0212A to C.M.-T.), the Emerson foundation grant 643577 (to L.V.), grant PID2019-108082GA-I00 and PRE2020-093229 by the Spanish Ministry of Science, Innovation and Universities (MCIU/AEI/FEDER, UE), the German Research Foundation (DFG; projects MU1328/18-1 and MU1328/21-1 and MU1328/23-1 to C.M.-T.), and the German Cancer Aid (DKH; project 70113908 to C.M.-T.). L.V. acknowledges support of the Spanish Ministry of Science and Innovation to the EMBL partnership, the Centro de Excelencia Severo Ochoa and the CERCA Programme/Generalitat de Catalunya. C.M.-T., A.K.M., and J.-A.K. gratefully acknowledge the data storage service SDS@hd supported by the Ministry of Science, Research and the Arts Baden-Württemberg (MWK) and the German Research Foundation (DFG) through grant INST 35/1314-1 FUGG and INST 35/1503-1 FUGG. J.-A.K. acknowledges support of the Deutsche Gesellschaft für Hämatologie und Medizinische Onkologie e.V. (DGHO) and Deutsche José Carreras Leukämie-Stiftung e.V. through the José Carreras-DGHO-Promotionsstipendium.
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

Design principles of cell-state-specific enhancers in hematopoiesis

  • Frömel, Robert
  • Rühle, Julia
  • Bernal, Aina
  • Szu-Tu, Chelsea
  • Pacheco Pastor, Felix
  • Martínez Corral, Rosa, 1991-
  • Velten, Lars
During cellular differentiation, enhancers transform overlapping gradients of transcription factors (TFs) to highly specific gene expression patterns. However, the vast complexity of regulatory DNA impedes the identification of the underlying cis-regulatory rules. Here, we characterized 64,400 fully synthetic DNA sequences to bottom-up dissect design principles of cell-state-specific enhancers in the context of the differentiation of blood stem cells to seven myeloid lineages. Focusing on binding sites for 38 TFs and their pairwise interactions, we found that identical sites displayed both repressive and activating function as a consequence of cell state, site combinatorics, or simply predicted occupancy of a TF on an enhancer. Surprisingly, combinations of activating sites frequently neutralized one another or gained repressive function. These negative synergies convert quantitative imbalances in TF expression into binary activity patterns. We exploit this principle to automatically create enhancers with specificity to user-defined combinations of hematopoietic progenitor cell states from scratch., This study was financed by grants from the Spanish Ministry of Science, Innovation and Universities MCIU/AEI/10.13039/501100011033 (grant PID2019-108082GA-I00 to L.V.; and grant RYC2021-033860-I cofounded by European Union NextGenerationEU/PRTR to R.M.-C.), the Ministry of Science and Innovation (PID2022-142210NA-I00 funded by MCIN/AEI/10.13039/501100011033 / FEDER, UE to R.M.-C.; and pre-doctoral fellowship PRE2021-097675 funded by MCIN/AEI/10.13039/501100011033 and FSE+ to J.R.). This project has received funding from the European Union's Horizon Europe under the grant agreement no. 101041399 (ERC-StG AI4SYN to L.V.). F.P.P. was supported by the predoctoral program AGAUR-FI grants (2023 FI_I 00776), Joan Oró of the Secretariat of Universities and Research of the Department of Research and Universities of the Generalitat de Catalunya, and the European Social Fund Plus. The authors acknowledge support by the Spanish Ministry of Science and Innovation through the Centro de Excelencia Severo Ochoa (CEX2020-001049-S and MCIN/AEI /10.13039/501100011033) and the Generalitat de Catalunya through the CERCA programme and to the EMBL partnership. We are grateful to the CRG Core Technologies Programme for their support and assistance in this work. Research for this publication has been partially carried out in the Barcelona Collaboratorium for Modelling and Predictive Biology.